Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 5769 | 132 | 0.2951 | 0.3050 | 0.0229 | 0.0212 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 5747 | 125 | 0.2943 | 0.3050 | 0.0218 | 0.0212 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 2 | 4759 | 106 | 0.2436 | 0.2452 | 0.0223 | 0.0214 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 4787 | 110 | 0.2448 | 0.2452 | 0.0230 | 0.0214 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 1 | 4811 | 91 | 0.2471 | 0.2452 | 0.0189 | 0.0214 |
A-375 | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 1 | 3770 | 78 | 0.2322 | 0.2659 | 0.0207 | 0.0217 |
A-375 | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 2 | 4429 | 94 | 0.2727 | 0.2659 | 0.0212 | 0.0217 |
A-375 | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 3 | 4768 | 111 | 0.2929 | 0.2659 | 0.0233 | 0.0217 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 4327 | 93 | 0.2216 | 0.2010 | 0.0215 | 0.0218 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 4016 | 78 | 0.2061 | 0.2010 | 0.0194 | 0.0218 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 3 | 3430 | 84 | 0.1752 | 0.2010 | 0.0245 | 0.0218 |
A-375 | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 3 | 4571 | 110 | 0.2427 | 0.2505 | 0.0241 | 0.0221 |
A-375 | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 2 | 5069 | 97 | 0.2705 | 0.2505 | 0.0191 | 0.0221 |
A-375 | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 1 | 4486 | 104 | 0.2384 | 0.2505 | 0.0232 | 0.0221 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 5737 | 112 | 0.2848 | 0.2652 | 0.0195 | 0.0225 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 2 | 5304 | 139 | 0.2615 | 0.2652 | 0.0262 | 0.0225 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 1 | 5034 | 110 | 0.2493 | 0.2652 | 0.0219 | 0.0225 |
A-375 | Vemurafenib | Defactinib | 0.100 | 1.000 | uM | 72 | hr | 3 | 4607 | 112 | 0.2154 | 0.2489 | 0.0243 | 0.0226 |
A-375 | Vemurafenib | Defactinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 5692 | 119 | 0.2671 | 0.2489 | 0.0209 | 0.0226 |
A-375 | Vemurafenib | Defactinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 5639 | 128 | 0.2641 | 0.2489 | 0.0227 | 0.0226 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 3 | 6531 | 140 | 0.4020 | 0.3831 | 0.0214 | 0.0229 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 1 | 5860 | 137 | 0.3600 | 0.3831 | 0.0234 | 0.0229 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 2 | 6306 | 150 | 0.3872 | 0.3831 | 0.0238 | 0.0229 |
A-375 | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 2 | 3786 | 100 | 0.2005 | 0.1991 | 0.0264 | 0.0233 |
A-375 | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 3 | 3852 | 93 | 0.2045 | 0.1991 | 0.0241 | 0.0233 |